⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
🇬🇧
🧸 Product IT March 15, 2024

SINTLAC — SINTLAC SMALTO

Varnish, walnut colour, 750 ml.

📷 Safety Gate / European Commission · Source
SINTLAC — SINTLAC SMALTO
📷 Safety Gate / European Commission · Source
Risk level
Serious risk
Type
Chemical
Category
Chemical products
Hazard
According to the list of ingredients, the product contains butanone oxime. Butanone oxime is toxic if swallowed, may cause cancer, causes damage to organs, is harmful in contact with skin, causes serious eye damage, causes skin irritation, may cause an allergic skin reaction and may cause drowsiness or dizziness.
Origin
Italy

⚖️ Actions ordered by authorities

  • (to: Manufacturer) Ban on the marketing of the product and any accompanying measures
🗄
Archived (older alert)
This alert was reported 806 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
13 days in total
May 17, 2026 May 30, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is a bottle of Sintlac Smalto paint. It has a chemical called butanone oxime in it.

What's happening? Butanone oxime is dangerous. It can hurt you if you swallow it, touch it, or get it in your eyes.

Does this affect me? If you have this paint at home, you could be at risk.

What should I do? Stop using it right away. Ask your pharmacist or doctor what to do next.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
Agency-published detail

Risk level: Serious risk · Type: Chemical · Category: Chemical products · Hazard: According to the list of ingredients, the product contains butanone oxime. Butanone oxime is toxic if swallowed, may cause cancer, causes damage to organs, is harmful in contact with skin, causes serious eye damage, causes skin irritation, may cause an allergic skin reaction and may cause drowsiness or dizziness. · Origin: Italy

First published
March 15, 2024
Last refreshed by us
1 week ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10011178

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this product recall alert about?
SINTLAC — SINTLAC SMALTO. Risk level: Serious risk · Type: Chemical · Category: Chemical products · Hazard: According to the list of ingredients, the product contains butanone oxime. Butanone oxime is toxic if swallowed, may cause cancer, causes damage to organs, is harmful in contact with skin, causes se...
When was this alert issued?
This alert was issued on March 15, 2024 by EU Safety Gate.
Which countries are affected?
The alert applies to Italy.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.